Odds ratio

Last updated: November 01, 2022

Odds ratio

Year 1

Year 1

Skin histology
Introduction to pharmacology
Skin anatomy and physiology
Wound healing
Introduction to biostatistics
Types of data
Vaccinations
Inflammation
Nuclear structure
Pharmacodynamics: Agonist, partial agonist and antagonist
DNA structure
Anemia: Clinical
Anatomy of the heart
Hypertension
Hypertension: Clinical
Myocardial infarction
Clinical trials
Mitosis and meiosis
Calcium channel blockers
Class III antiarrhythmics: Potassium channel blockers
Pharmacokinetics: Drug elimination and clearance
Pharmacokinetics: Drug metabolism
Pharmacokinetics: Drug absorption and distribution
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Opioid agonists, mixed agonist-antagonists and partial agonists
Cardiac muscle histology
Blood histology
Artery and vein histology
Arteriole, venule and capillary histology
Loop diuretics
Thiazide and thiazide-like diuretics
Potassium sparing diuretics
Osmotic diuretics
Carbonic anhydrase inhibitors
Bone histology
Cartilage histology
Skeletal muscle histology
Central nervous system histology
Peripheral nervous system histology
Diabetes mellitus
Phenylketonuria (NORD)
Homocystinuria
Familial hypercholesterolemia
Fats and lipids
Cholesterol metabolism
Carbohydrates and sugars
Proteins
Extracellular matrix
Cytoskeleton and intracellular motility
Cell signaling pathways
Citric acid cycle
Electron transport chain and oxidative phosphorylation
Amino acid metabolism
Nitrogen and urea cycle
Nucleotide metabolism
Introduction to biostatistics
Types of data
Probability
Mean, median, and mode
Range, variance, and standard deviation
Standard error of the mean (Central limit theorem)
Normal distribution and z-scores
Type I and type II errors
Study designs
Ecologic study
Cross sectional study
Case-control study
Cohort study
Randomized control trial
Sensitivity and specificity
Positive and negative predictive value
Test precision and accuracy
Atrophy, aplasia, and hypoplasia
Hyperplasia and hypertrophy
Metaplasia and dysplasia
Bone tumors
Osteomyelitis
Osteoporosis
Osteomalacia and rickets
Septic arthritis
Cauda equina syndrome
The Oral Microbiota and Systemic Health
Bacterial structure and functions
Nasal cavity and larynx histology
Trachea and bronchi histology
Bronchioles and alveoli histology
Inheritance patterns
Mendelian genetics and punnett squares
Hardy-Weinberg equilibrium
DNA mutations
Neuromuscular junction and motor unit
Pharmacodynamics: Drug-receptor interactions
Cholinergic receptors
Adrenergic receptors
Blood products and transfusion: Clinical
Muscle contraction
Sliding filament model of muscle contraction
Nervous system anatomy and physiology
Parasympathetic nervous system
Slow twitch and fast twitch muscle fibers
Enteric nervous system
Sympathetic nervous system
Resting membrane potential
Neuron action potential
Cell membrane
Selective permeability of the cell membrane
Blood groups and transfusions
Blood components
Oxygen binding capacity and oxygen content
Oxygen-hemoglobin dissociation curve
Body fluid compartments
Movement of water between body compartments
Platelet plug formation (primary hemostasis)
Coagulation (secondary hemostasis)
Clot retraction and fibrinolysis
Carbon dioxide transport in blood
Bones of the vertebral column
Bones of the vertebral column
Joints of the vertebral column
Joints of the vertebral column
Joints of the wrist and hand
Bones of the upper limb
Fascia, vessels and nerves of the upper limb
Anatomy of the brachial plexus
Anatomy of the arm
Muscles of the forearm
Vessels and nerves of the forearm
Muscles of the hand
Anatomy of the sternoclavicular and acromioclavicular joints
Anatomy of the glenohumeral joint
Anatomy of the elbow joint
Anatomy of the radioulnar joints
Paired t-test
Two-sample t-test
Hypothesis testing: One-tailed and two-tailed tests
Methods of regression analysis
Spearman's rank correlation coefficient
Mann-Whitney U test
Chi-squared test
Kaplan-Meier survival analysis
Incidence and prevalence
Relative and absolute risk
Odds ratio
Attributable risk (AR)
Direct standardization
Indirect standardization
Disease causality
Selection bias
Information bias
Confounding
Innate immune system
Complement system
T-cell activation
B-cell activation, differentiation, and contraction
Cell-mediated immunity of natural killer and CD8 cells
Antibody classes
Upper respiratory tract infection
Heart failure
Lipid-lowering medications: Statins
Lipid-lowering medications: Fibrates
Miscellaneous lipid-lowering medications
Dyslipidemias: Pathology review
Atherosclerosis and arteriosclerosis: Pathology review
Familial hypercholesterolemia
Deep vein thrombosis and pulmonary embolism: Pathology review
Chronic venous insufficiency
Ischemia
ECG cardiac infarction and ischemia
Angina pectoris
Aneurysms
Asthma: Clinical
Chronic bronchitis
Emphysema
Pulmonary hypertension
Idiopathic pulmonary fibrosis
Bronchiectasis
Lung cancer
Chronic obstructive pulmonary disease (COPD): Clinical
Respiratory distress syndrome: Pathology review
Myocardial infarction
Vasculitis
ACE inhibitors, ARBs and direct renin inhibitors
Adrenergic receptors
Adrenergic antagonists: Alpha blockers
Class II antiarrhythmics: Beta blockers
Adrenergic antagonists: Beta blockers
Antiplatelet medications
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Calcium channel blockers
cGMP mediated smooth muscle vasodilators
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Pulmonary corticosteroids and mast cell inhibitors
Arteriole, venule and capillary histology
Microcirculation and Starling forces
Blood pressure, blood flow, and resistance
Resistance to blood flow
Lymphatic system anatomy and physiology
Laminar flow and Reynolds number
Compliance of blood vessels
Pressures in the cardiovascular system
Physiological changes during exercise
Measuring cardiac output (Fick principle)
Stroke volume, ejection fraction, and cardiac output
Frank-Starling relationship
Pressure-volume loops
Changes in pressure-volume loops
Cardiac work
Cardiac preload
Cardiac afterload
Law of Laplace
Baroreceptors
Renin-angiotensin-aldosterone system
Chemoreceptors
Cardiac conduction system
Action potentials in pacemaker cells
Action potentials in myocytes
Cardiac excitation-contraction coupling
Cardiac contractility
ECG basics
Cerebral circulation
Coronary circulation
Respiratory system anatomy and physiology
Reading a chest X-ray
Lung volumes and capacities
Anatomic and physiologic dead space
Alveolar surface tension and surfactant
Ventilation
Regulation of pulmonary blood flow
Zones of pulmonary blood flow
Pulmonary shunts
Ventilation-perfusion ratios and V/Q mismatch
Airflow, pressure, and resistance
Diffusion-limited and perfusion-limited gas exchange
Gas exchange in the lungs, blood and tissues
Oxygen binding capacity and oxygen content
Oxygen-hemoglobin dissociation curve
Carbon dioxide transport in blood
Carpal tunnel syndrome

Transcript

Watch video only

In statistics, the words probability and odds are often confused with each other, because they help measure the same thing - the chance that an outcome will occur - and in both cases, we need to know the same two things - the number of times an outcome actually happened, or didn’t happen, and the total number of times an outcome could have happened.

The probability is the number of times an outcome happened divided by the number of times the outcome could have happened, and is often represented by a capital P.

For example, let’s say we want to figure out the probability of having a heart attack for people with hypertension - or high blood pressure.

To do this, we could carry out a cohort study which is where we start with two exposure groups and follow them over time to see if they develop a certain outcome.

We could recruit 100 people with hypertension, The exposed group - and 100 people without hypertension - the non-exposed group - and organize our results in a 2 by 2 table, and keep track of how many of them have heart attacks in the next year.

The two outcomes - heart attack or no heart attack - labeled on the top, and the two exposure groups - hypertension or no hypertension - on the side, and each of the cells inside the box labeled as a, b, c, or d.

Now, let’s say there are 9 people that have heart attacks in the group with hypertension - cell a - and 3 people that have heart attacks in the group without hypertension - cell c.

That means that there are 100 minus 9, or 91, people that didn’t have heart attacks in the group with hypertension - cell b - and 100 minus 3, or 97, people that didn’t have heart attacks in the group without hypertension - cell d.

To calculate the relative risk, we need the probability of having a heart attack in the group with hypertension - so cell a, 9, divided by cell a plus cell b or 100, which gives us 0.09.

We also need the probability of having a heart attack in the group that doesn’t have hypertension - so cell c, 3, divided by cell c plus cell d, 100, which gives us 0.03.

The relative risk is 0.09 divided by 0.03, so 3, which means that people who have hypertension have 3 times the risk of having a heart attack in one year compared to people without hypertension.

The probability of having a heart attack in the past year for people with hypertension is 9 divided by 100, and the result can be written as a decimal - 0.09 - or a percentage - 9%.

On the flip side, we could also find the probability of not having a heart attack for people with hypertension.

A simple way to do this is to subtract the probability of having a heart attack from 1, or 100%.

So, the probability of not having a heart attack for people with hypertension is 1 minus 0.09, which equals 0.91, or 91%.

Now, the relative risk can only be calculated when we have information about incidence, or the probability of a new outcome occurring during a certain time period.

That’s because the word risk implies that hypertension is responsible for causing, or at least partially causing, heart attacks to happen.

And, if hypertension causes heart attacks to happen, then a person would have to have hypertension before they have a heart attack, which can only be measured by incidence - which measures new events.

But sometimes information on incidence can’t be collected, so relative risk can’t be calculated.

For example, case-control studies start with a case group, that already has the outcome, and a control group, that doesn’t have the outcome - and looks at past exposures.

In this situation, odds and odds ratios come in very handy.

Odds compare the probability of an outcome occurring with the probability of an outcome not occurring, so it’s P compared with 1 minus P.

So in our hypertension example, we’d use the probability of having a heart attack - 0.09 - compared with the probability of not having a heart attack, 1 minus 0.09, or 0.91.

Dividing both sides by 0.91, we get 0.0989 compared to 1, and rounding off we can say that it’s 0.1 compared to 1, and multiplying by 10, we get an odds of 1 to 10.

In other words, in one year, for every 1 person with hypertension who has a heart attack, there are 10 people with hypertension who do not have a heart attack.

In fact, the odds will always be slightly higher than the probability of an event, but the odds and the probability end up being very similar when an outcome is rare - specifically when it’s found in less than 10% of the population.

Key Takeaways

The odds ratio (OR) is a statistical measure used to compare the odds of an event occurring in one group to the odds of the same event occurring in another group. It is often used in retrospective studies, such as case-control studies, to compare the likelihood of an outcome (such as a disease or condition) occurring in one group of people compared to another group.

The odds ratio is calculated by dividing the odds of the event occurring in one group by the odds of the event occurring in the other group. For example, if the odds of a disease occurring in group A are 1 in 10, and the odds of the disease occurring in group B are 1 in 20, the odds ratio would be (1/10) / (1/20) = 2. This indicates that the odds of the disease occurring in group A are twice as high as the odds of the disease occurring in group B.